The Impact of COVID-19 on the HIV Care Continuum in a Large Urban Southern Clinic

AIDS Behav. 2022 Aug;26(8):2825-2829. doi: 10.1007/s10461-022-03615-7. Epub 2022 Feb 23.

Abstract

Access to care is essential for people with HIV (PWH) but may have been affected during the COVID-19 pandemic. We conducted a retrospective cross-sectional study of adult PWH receiving care in a large southeastern comprehensive care clinic in the United States. Patients in care between January 1, 2017, and July 30, 2020, were included. Race/ethnicity, sex, HIV-1 RNA, CD4 + lymphocyte count were included as baseline covariates. Outcomes included clinic attendance, receipt of HIV-1 RNA PCR testing, and virologic suppression (HIV-1 RNA < 200 copies/mL); outpatient encounters included new patient encounters, follow-up visits, and mental health encounters. Total medical encounters, including telemedicine, decreased by 827 visits (33%) when comparing the second quarters of 2019 and 2020. New patient encounters decreased by 23.5% from 81 to 62 during this period. The second quarter of 2020 saw the lowest number of new patient visits since 2017. HIV-1 RNA testing and the proportion of patients with virologic suppression decreased during the pandemic (p < 0.001 for both). Total mental health encounters, on the other hand, increased by 14% during April-June 2020 compared to April-June 2019. Mental health electronic communications increased by 60% from 312 to 500 during the same period, with a 20% increase in medication refills. The COVID-19 pandemic affected outpatient visits, viral load surveillance, and virologic suppression but led to an increase in mental health encounters in a comprehensive care clinic setting.

Keywords: COVID-19; Care continuum; HIV; Mental health.

MeSH terms

  • Adult
  • COVID-19* / epidemiology
  • Continuity of Patient Care
  • Cross-Sectional Studies
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • Humans
  • Pandemics
  • RNA / therapeutic use
  • Retrospective Studies
  • United States
  • Viral Load

Substances

  • RNA